DE69220050D1 - Verfahren zur inhibierung der fibrose - Google Patents

Verfahren zur inhibierung der fibrose

Info

Publication number
DE69220050D1
DE69220050D1 DE69220050T DE69220050T DE69220050D1 DE 69220050 D1 DE69220050 D1 DE 69220050D1 DE 69220050 T DE69220050 T DE 69220050T DE 69220050 T DE69220050 T DE 69220050T DE 69220050 D1 DE69220050 D1 DE 69220050D1
Authority
DE
Germany
Prior art keywords
formula
inhibiting
alkyl
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69220050T
Other languages
English (en)
Other versions
DE69220050T2 (de
Inventor
Saood Murad
Sheldon Pinnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Application granted granted Critical
Publication of DE69220050D1 publication Critical patent/DE69220050D1/de
Publication of DE69220050T2 publication Critical patent/DE69220050T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69220050T 1991-04-01 1992-03-31 Verfahren zur inhibierung der fibrose Expired - Fee Related DE69220050T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67847291A 1991-04-01 1991-04-01
PCT/US1992/002618 WO1992017065A2 (en) 1991-04-01 1992-03-31 Method of inhibiting fibrosis

Publications (2)

Publication Number Publication Date
DE69220050D1 true DE69220050D1 (de) 1997-07-03
DE69220050T2 DE69220050T2 (de) 1998-01-22

Family

ID=24722926

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69220050T Expired - Fee Related DE69220050T2 (de) 1991-04-01 1992-03-31 Verfahren zur inhibierung der fibrose

Country Status (11)

Country Link
US (2) US5374660A (de)
EP (1) EP0581904B1 (de)
JP (1) JPH06506471A (de)
AT (1) ATE153500T1 (de)
AU (1) AU652644B2 (de)
CA (1) CA2107371A1 (de)
DE (1) DE69220050T2 (de)
DK (1) DK0581904T3 (de)
ES (1) ES2104938T3 (de)
GR (1) GR3024548T3 (de)
WO (1) WO1992017065A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2104938T3 (es) * 1991-04-01 1997-10-16 Univ Duke Metodo de inhibir la fibrosis.
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US6117445A (en) * 1998-01-28 2000-09-12 Link Technology Inc. Methods for the prevention and treatment of fibrosis and sclerosis
CA2559476C (en) 2004-03-12 2012-12-11 Intercept Pharmaceuticals, Inc. Treatment of fibrosis using fxr ligands
AT509045B1 (de) 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
RU2698195C2 (ru) 2013-02-07 2019-08-23 Сайфлуор Лайф Сайенсиз, Инк Фторсодержащие антагонисты интегрина
EP3259271B1 (de) 2015-02-19 2021-05-05 SciFluor Life Sciences, Inc. Fluorierte derivate von 3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propansäure und verwendungen davon
CA2983312A1 (en) 2015-04-30 2016-11-03 Scifluor Life Sciences, Inc. Tetrahydronaphthyridinyl propionic acid derivatives and uses thereof
WO2017189828A1 (en) 2016-04-27 2017-11-02 Scifluor Life Sciences, Inc. Nonanoic and decanoic acid derivatives and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB828344A (en) * 1957-01-30 1960-02-17 Ici Ltd Veterinary compositions containing acid hydrazides
JPS5119135A (en) * 1974-08-05 1976-02-16 Itsuo Takeshita Kohakusenzaino seiho
US4321273A (en) * 1978-03-01 1982-03-23 Ryuichi Sato Germanium-containing organic polymer and its use in the treatment of pulmonary fibrosis
US4382941A (en) * 1980-11-26 1983-05-10 Sicardi Susana M Bishydrazide quaternary salts and pharmaceutical compositions thereof
HU207051B (en) * 1987-12-30 1993-03-01 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds
ES2104938T3 (es) * 1991-04-01 1997-10-16 Univ Duke Metodo de inhibir la fibrosis.

Also Published As

Publication number Publication date
ATE153500T1 (de) 1997-06-15
EP0581904A4 (en) 1994-05-25
DE69220050T2 (de) 1998-01-22
JPH06506471A (ja) 1994-07-21
AU1876392A (en) 1992-11-02
AU652644B2 (en) 1994-09-01
WO1992017065A2 (en) 1992-10-15
DK0581904T3 (da) 1997-12-29
GR3024548T3 (en) 1997-12-31
US5374660A (en) 1994-12-20
WO1992017065A3 (en) 1992-11-26
EP0581904B1 (de) 1997-05-28
ES2104938T3 (es) 1997-10-16
US5571846A (en) 1996-11-05
EP0581904A1 (de) 1994-02-09
CA2107371A1 (en) 1992-10-02

Similar Documents

Publication Publication Date Title
TW255881B (de)
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
KR870005973A (ko) 항염증성 및 진통성의 활성을 갖는 벤조산 및 벤조산 에스테르의 유도체
ES8701228A1 (es) Un metodo para producir una propioxantina
ATE153500T1 (de) Verfahren zur inhibierung der fibrose
ES8604991A1 (es) Un metodo para preparar peptidos farmaceuticamente activos
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
ES8500899A1 (es) Procedimiento para preparar derivados de amidas de los acidos mercaptoacetico y 3-mercaptopropionico
TW248530B (de)
SG81889A1 (en) Pharmaceutical compositions for use in treating aids
NO950177L (no) Farmakologisk aktive erivater
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
DE3885978D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee